Get all your news in one place.
100's of premium titles.
One app.
Start reading
Top News
Top News
Health

EXPLAINED: Ozempic and wegovy show lower risk of suicidal thoughts | Rare Historical Photos

This image provided by Novo Nordisk on Friday, June 4, 2021 shows a package of injection pens for the company's semaglutide medication, named Wegovy.

In a world filled with pharmaceutical advancements and medical breakthroughs, a recent federal study has shed light on the possible benefits of two popular drugs, Ozempic and Wegovy. These drugs, primarily prescribed for diabetes and obesity management, have been found to be associated with a lower risk of suicidal thoughts compared to other medications used for the same conditions. Talk about an unexpected twist!

Funded by the National Institutes of Health and conducted by researchers from Case Western Reserve University, the study analyzed the electronic medical records of over 1.8 million patients who were prescribed semaglutide or another drug for diabetes or obesity between the years 2017 and 2022. The results were nothing short of surprising. It turns out that patients taking semaglutide had a significantly reduced risk, ranging from 49% to 73%, of experiencing suicidal thoughts compared to those on alternative medications during the follow-up period of six months.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.